$0.00
(0.00%
) Quote detailsUSD
$0.00
(0.00%
)At Close (As of Dec 11, 2025)
$59.80M
Market Cap
-
P/E Ratio
-3.01
EPS
$76.00
52 Week High
$4.56
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
MiNK Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in New York, dedicated to developing innovative allogeneic invariant natural killer T-cell therapies aimed at addressing cancer and immune-mediated diseases. With a focus on harnessing the unique properties of these immune cells, MiNK is positioning itself at the forefront of next-generation cell-based immunotherapies. The company is committed to pioneering novel treatment options that have the potential to significantly enhance patient outcomes and transform therapeutic strategies in the oncology and immunology landscapes.
LPTX
NVDA
WOK
VSME
PETS
PLUG
ORCL
ASST
KIND
IVP
IRBT
INTC
F
KVUE
TSLA
ADAP
DNN
AAL
AVGO
HOOD
MARA
NFLX
WBD
GOOGL
SOFI
RR
VALE
NIO
T
RGTI
BYND
PLTR
BAC
PFE
HL
ASBP
PLTD
GRAB
BITF
HPE
RKLB
QBTS
RIG
JBLU
AMD
CIFR
AG
CDE
SNAP
MTSR
BTBT
NCLH
IREN
FI
GOOG
NOK
MSFT
HBAN
CCL
PCG
UBER
SMCI
KO
WULF
LUV
SOUN
SMR
CNQ
VZ
CLSK
LPTX
NVDA
WOK
VSME
PETS
PLUG
ORCL
ASST
KIND
IVP
IRBT
INTC
F
KVUE
TSLA
ADAP
DNN
AAL
AVGO
HOOD
MARA
NFLX
WBD
GOOGL
SOFI
RR
VALE
NIO
T
RGTI
BYND
PLTR
BAC
PFE
HL
ASBP
PLTD
GRAB
BITF
HPE
RKLB
QBTS
RIG
JBLU
AMD
CIFR
AG
CDE
SNAP
MTSR
BTBT
NCLH
IREN
FI
GOOG
NOK
MSFT
HBAN
CCL
PCG
UBER
SMCI
KO
WULF
LUV
SOUN
SMR
CNQ
VZ
CLSK